The KDIGO CKD 2024 Guideline Draft
It’s time for another NephJC draft! This time, the crew breaks down the 2024 KDIGO chronic kidney disease (CKD) guideline. This was the first update since 2012.
FDA Approves Mepolizumab as Add-On Treatment for COPD
Balancing Fertility and Cancer Risk in BRCA+ Young Women
Risk-Reducing Surgery Linked to Survival in Young BRCA Carriers